Papers by Louiza Belkacemi
F1000 - Post-publication peer review of the biomedical literature, 2000
Bookmarks Related papers MentionsView impact
F1000 - Post-publication peer review of the biomedical literature, 2000
Bookmarks Related papers MentionsView impact
F1000 - Post-publication peer review of the biomedical literature, 2000
Bookmarks Related papers MentionsView impact
F1000 - Post-publication peer review of the biomedical literature, 2013
Bookmarks Related papers MentionsView impact
F1000 - Post-publication peer review of the biomedical literature, 2000
Bookmarks Related papers MentionsView impact
F1000 - Post-publication peer review of the biomedical literature, 2000
Bookmarks Related papers MentionsView impact
Impact of Maternal Nutrition, 2015
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
The Journal of Clinical Endocrinology and Metabolism, Sep 1, 2005
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Cancer Informatics, 2016
Efficacies, toxicities, and resistance mechanisms of chemotherapy drugs, such as oxaliplatin and ... more Efficacies, toxicities, and resistance mechanisms of chemotherapy drugs, such as oxaliplatin and 5-fluorouracil (5-FU), vary widely among various categories and subcategories of colon cancers. By understanding the differences in the drug efficacy and resistance at the level of protein-protein networks, we identified the correlation between the drug activity of oxaliplatin/5-FU and gene variations from the US National Cancer Institute-60 human cancer cell lines. The activity of either of these drugs is correlated with specific amino acid variant(s) of KRAS and other genes from the signaling pathways of colon cancer progression. We also discovered that the activity of a non-DNA-binding novel platinum drug, phosphaplatin, is comparable with oxaliplatin and 5-FU when it was tested against colon cancer cell lines. Our strategy that combines the knowledge from pharmacogenomics across cell lines with the molecular information from specific cancer cells is beneficial for predicting the outcome of a possible combination therapy for personalized treatment.
Bookmarks Related papers MentionsView impact
Amer J Obstet Gynecol, 2009
Bookmarks Related papers MentionsView impact
Endocrine, 2002
Bookmarks Related papers MentionsView impact
Data Revues 00029378 V199i6ssa S0002937808015500, Aug 21, 2011
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Cancer cells acquire the ability to penetrate into lymphatic and blood vessels, circulate through... more Cancer cells acquire the ability to penetrate into lymphatic and blood vessels, circulate through the bloodstream, and then invade to grow in normal tissues elsewhere. In large measure, its invasive nature to other tissues and organs makes cancer a potentially life-threatening ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Uploads
Papers by Louiza Belkacemi